Differentiation of neuroblastoma, glioma, and hybrid cells in culture as measured by the synthesis of specific protein species: evidence for neuroblast-glioblast reciprocal genetic regulation. 1978

R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006822 Hybrid Cells Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION. Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations

Related Publications

R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1981, Cellular and molecular biology, including cyto-enzymology,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
June 1994, Cell biochemistry and function,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1999, Neuroscience,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
September 1994, Brain research,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1972, Proceedings of the National Academy of Sciences of the United States of America,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1985, Methods in enzymology,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
October 2011, The European journal of neuroscience,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
March 1978, Proceedings of the National Academy of Sciences of the United States of America,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1983, The EMBO journal,
R N Rosenberg, and C K Vance, and M Morrison, and N Prashad, and J Meyne, and F Baskin
January 1976, Advances in prostaglandin and thromboxane research,
Copied contents to your clipboard!